Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.

Saved in:
Bibliographic Details
Title: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Authors: Sharman, Jeff P.1 (AUTHOR) jeff.sharman@usoncology.com, Forero-Torres, Andres2 (AUTHOR), Costa, Luciano J.3 (AUTHOR), Flinn, Ian W.4 (AUTHOR), Inhorn, Lowell5 (AUTHOR), Kelly, Kevin6 (AUTHOR), Bessudo, Alberto7 (AUTHOR), Fayad, Luis E.8 (AUTHOR), Kaminski, Mark S.9 (AUTHOR), Evens, Andrew M.10 (AUTHOR), Flowers, Christopher R.11 (AUTHOR), Sahin, Deniz12 (AUTHOR), Mundt, Kirsten E.12 (AUTHOR), Sandmann, Thomas13 (AUTHOR), Fingerle-Rowson, Günter12 (AUTHOR), Vignal, Charlotte12 (AUTHOR), Mobasher, Mehrdad13 (AUTHOR), Zelenetz, Andrew D.14 (AUTHOR)
Source: Leukemia & Lymphoma. Apr2019, Vol. 60 Issue 4, p894-903. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 135800918
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Sharman%2C+Jeff+P%2E%22">Sharman, Jeff P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jeff.sharman@usoncology.com</i><br /><searchLink fieldCode="AR" term="%22Forero-Torres%2C+Andres%22">Forero-Torres, Andres</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Costa%2C+Luciano+J%2E%22">Costa, Luciano J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flinn%2C+Ian+W%2E%22">Flinn, Ian W.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inhorn%2C+Lowell%22">Inhorn, Lowell</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kelly%2C+Kevin%22">Kelly, Kevin</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bessudo%2C+Alberto%22">Bessudo, Alberto</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fayad%2C+Luis+E%2E%22">Fayad, Luis E.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaminski%2C+Mark+S%2E%22">Kaminski, Mark S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Evens%2C+Andrew+M%2E%22">Evens, Andrew M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flowers%2C+Christopher+R%2E%22">Flowers, Christopher R.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sahin%2C+Deniz%22">Sahin, Deniz</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mundt%2C+Kirsten+E%2E%22">Mundt, Kirsten E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sandmann%2C+Thomas%22">Sandmann, Thomas</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fingerle-Rowson%2C+Günter%22">Fingerle-Rowson, Günter</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vignal%2C+Charlotte%22">Vignal, Charlotte</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mobasher%2C+Mehrdad%22">Mobasher, Mehrdad</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zelenetz%2C+Andrew+D%2E%22">Zelenetz, Andrew D.</searchLink><relatesTo>14</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Apr2019, Vol. 60 Issue 4, p894-903. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=135800918
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2018.1515940
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 894
    Titles:
      – TitleFull: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sharman, Jeff P.
      – PersonEntity:
          Name:
            NameFull: Forero-Torres, Andres
      – PersonEntity:
          Name:
            NameFull: Costa, Luciano J.
      – PersonEntity:
          Name:
            NameFull: Flinn, Ian W.
      – PersonEntity:
          Name:
            NameFull: Inhorn, Lowell
      – PersonEntity:
          Name:
            NameFull: Kelly, Kevin
      – PersonEntity:
          Name:
            NameFull: Bessudo, Alberto
      – PersonEntity:
          Name:
            NameFull: Fayad, Luis E.
      – PersonEntity:
          Name:
            NameFull: Kaminski, Mark S.
      – PersonEntity:
          Name:
            NameFull: Evens, Andrew M.
      – PersonEntity:
          Name:
            NameFull: Flowers, Christopher R.
      – PersonEntity:
          Name:
            NameFull: Sahin, Deniz
      – PersonEntity:
          Name:
            NameFull: Mundt, Kirsten E.
      – PersonEntity:
          Name:
            NameFull: Sandmann, Thomas
      – PersonEntity:
          Name:
            NameFull: Fingerle-Rowson, Günter
      – PersonEntity:
          Name:
            NameFull: Vignal, Charlotte
      – PersonEntity:
          Name:
            NameFull: Mobasher, Mehrdad
      – PersonEntity:
          Name:
            NameFull: Zelenetz, Andrew D.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 10428194
          Numbering:
            – Type: volume
              Value: 60
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Leukemia & Lymphoma
              Type: main
ResultId 1